donor-alloantigen-reactive regulatory t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02711826)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- donor-alloantigen-reactive regulatory t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04208919 | Phase 1/Phase 2 (Phase 2) | Dec 18, 2019 | University of Pittsburgh |
| NCT02711826 | Phase 1/Phase 2 (Phase 2) | May 1, 2016 | Clinical Trials in Organ Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clinical Trials in Organ Transplantation | Government | 1 | 0 | 1 | 2016 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2016 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1